Naturopathix and ZymaDerm™ in the NEWS

 

Dr. Burke was featured on the Better Business Bureau’s “BUSINESS AT ITS BEST” television show.

29-Mar-13
Naturopathix, Inc. Brings Painless Molluscum Treatment to Asia on Governor’s Trade Mission

Idaho Governor “Butch” Otter has invited Naturopathix,Inc., maker of all-natural patented ZymaDerm™ for molluscum, to participate in the Governor’s trade mission to Asia in April 2013. Meetings with distributors and retailers in Korea and Taiwan are anticipated to bring the painless treatment for molluscum developed by Briant Burke, MD, MS to these countries and open the door for distribution throughout Asia.

22-Jun-12
86% of Doctors Surveyed Prefer Painless Topical Application of ZymaDerm™ To Other Treatment Options For Molluscum Contagiosum

In an independent study of 346 physicians that used samples of ZymaDerm™, a natural non-toxic topical treatment for their patients with molluscum contagiosum, 92% of those responding rated it as effective, while 86% stated that they were either likely or extremely likely to use ZymaDerm™ as their preferred treatment method for molluscum contagiosum, compared to prescription drugs, over-the-counter treatment options, or physical destruction of lesions.


24-Mar-12
Zymaderm™ Effective for Treatment for Molluscum Says New Independent Medical Study

Scientific proof for the effectiveness of Zymaderm™ in the treatment of molluscum contagiosum was announced today by Naturopathix,Inc., with the publication of a randomized controlled clinical trial demonstrating that the combination of tea tree oil and organically bound iodine found in ZymaDerm™ is effective in reducing or eliminating molluscum lesions in over 85% of children in 30 days. The study was published in the March issue of the prestigious Journal of Drugs in Dermatology and conducted by the Center for Biomedical Research,Inc.


21-Feb-12
North Carolina Mutual Drug Selects Patented Zymaderm™ for Distribution

Naturopathix,Inc. announced today that North Carolina Mutual Drug Distribution has selected ZymaDerm™, a painless, safe, effective, patented treatment of molluscum contagiosum, for distribution to leading pharmacies in the South East. It joins distributors Smith Drug and drugstore chains Walgreens’s and Pharmaca Integrative Pharmacies that sell ZymaDerm™ in its stores, as well as leading online merchants that include Drugstore.com and Amazon.com.

29-Nov-11
Cardinal Health Selects Zymaderm™ for its Painless, Safe and Effective Treatment of Molluscum Contagiosum

Naturopathix announces that Cardinal Health selects ZymaDerm™ for its painless, safe and effective treatment of molluscum contagiosum for distribution to leading pharmacies nationwide. It joins distributors Smith Drug and drugstore chains that include Walgreens’s and Pharmaca Integrative Pharmacies that sell ZymaDerm™ in its stores, as well as leading online merchants that include Drugstore.com and Amazon.com.

2-June-10
Local Walgreen’s Drug Stores Now Stock ZymaDerm™ The Painless Treatment for Molluscum Contagiosum

Walgreen’s, the nation’s largest drugstore chain, has selected ZymaDerm™, the most widely used painless topical treatment for molluscum contagiosum, for sale at it’s local drugstores nationwide. Now it’s never been easier to make this embarrassing skin condition painlessly vanish in 30 days.

14-Mar-08
Extraordinary New Molluscum Contagiosum Treatment Awarded US Patent

Naturopathix, Inc. has been awarded US Patent #7,311,928 for its unique painless treatment for molluscum contagiosum, Dr. Briant Burke, MD announced today. Molluscum contagiosum is a skin malady common in children and found increasingly in adults. The product, ZymaDerm, is a plant based topical solution with unique skin penetrating abilities so it may be applied directly onto the intact molluscum bump, with no burning, painful squeezing, pin pricking or scraping required.

15-Feb-08
Developer of Novel Treatment for Molluscum Announces Naturopathix, Inc. Commercial Spin Off

Dr. Briant Burke, MD, developer of the patented, over-the-counter topical treatment for molluscum contagiosum called ZymaDerm, announced today that the Center for Biomedical Research, Inc. has launched a commercial spin off for e-commerce named Naturopathix, Inc.